Cipla
-
Cipla Receives Approval for Afrezza Insulin, Sales Begin in India
Indian pharmaceutical company Cipla has received approval from the Central Drugs Standard Control Organization (CDSCO) to distribute and market Afrezza,…
Read More » -
Latest News
Favipiravir a broad spectrum inhibitor of viral RNA polymerase emerges as one of most promising drugs for COVID19
CSIR identifies top 25 drugs/drug candidates for repurposing CSIR-IICT, based in Hyderabad, develops a convenient and cost effective synthetic process…
Read More »
